| Literature DB >> 34076041 |
Heather Coatsworth1, Paola A Caicedo2, Geoffrey Winsor3, Fiona Brinkman3, Clara B Ocampo2, Carl Lowenberger1.
Abstract
BACKGROUND: Forty percent of the world's population live in areas where they are at risk from dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. Dengue viruses are transmitted primarily by the mosquito Aedes aegypti. In Cali, Colombia, approximately 30% of field collected Ae. aegypti are naturally refractory to all four dengue serotypes.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34076041 PMCID: PMC8186470 DOI: 10.1590/0074-02760200547
Source DB: PubMed Journal: Mem Inst Oswaldo Cruz ISSN: 0074-0276 Impact factor: 2.743
Full factorial treatment design outlining all twelve experimental treatments (n = 36 for each treatment)
| Hours PBM | 24 | 36 | 48 | |||||||||
| Treatment | Blood | Blood + DENV-2 | Blood | Blood + DENV-2 | Blood | Blood + DENV-2 | ||||||
| Strain Cali- | S | MIB | S | MIB | S | MIB | S | MIB | S | MIB | S | MIB |
DENV: dengue viruses; MIB: midgut infection barrier; PBM: post blood meal.
Fig. 1:modified and adapted RNA rocket Galaxy portal bioinformatics workflow.
Fig. 2:significantly differentially expressed genes between Cali-S and Cali-MIB strains at 24, 36 and 48 h after ingesting dengue virus serotype 2, arranged by broad functional groups denoted by ImmunoDB.
Fig. 3:consensus hierarchical clustering result from DESeq2 (v. 1.16.0), Cuffdiff (v. 2.2.1) and GFOLD (v. 1.1.1) generated using R (v. 3.1.1). Clustering shows the phylogenetic relationship between all 12 treatment expression profiles (S: Cali-S, R: Cali-MIB, v: virus fed, b: blood fed, numbers represent time points). Euclidian distances were generated to compute Complete Linkage clustering.
List of candidate genes
| Gene ID | Gene name | Functional group | Up/Down | Function | Possible pathogen association | Reference |
| AAEL000693 | TOR | Autophagy | Up | Inhibits autophagy, promoting cell growth | Inhibition should prevent viral replication |
|
| AAEL003712 | C-type Lysozyme | Immunity | Up | Involved in innate immunity specifically in AMP expression | Lysozyme exerts a significant inhibitory effect on DENV |
|
| AAEL002360 | Serine-type endopeptidase | Digestion | Up | Digestive enzymes which assists in breaking down meals | Proteolytic activity of serine-type endopeptidases limits virus infectivity |
|
| AAEL005444 | Pyrokinin | Digestion and ionic balance | Up | Neuropeptide that regulates growth, metamorphosis, plays a role in anti-diuresis | Inhibits substrate absorption by anterior midgut |
|
| AAEL002992 | Sphingolipid delta 4 desaturase | Cell signaling | Up | Control cell proliferation, differentiation, and apoptosis |
| |
| AAEL005641 | C-type lectin | Binding | Up | Directly involved in cell galactose binding | Primary candidates for PRRs |
|
| AAEL001769 | RM62B (dead box ATP-dependent RNA helicase) | Immunity | Up | Guides the silencing of target transcripts within small RNA pathway | Small RNA pathway (PIWI) may limit DENV replication |
|
| AAEL010195 | Trypsin | Digestion | Up | Digestive enzyme which assists in breaking down meals | Higher trypsin expression results in higher DENV titers |
|
| AAEL013063 | Autophagy related gene | Autophagy | Up | Participates in autophagy, an intracellular degradation system initiated upon stress | Autophagy plays a supportive role in DENV replication |
|
| AAEL002083 | RM62C (dead box ATP-dependent RNA helicase) | Immunity | Up | Guides the silencing of target transcripts within small RNA pathway | Small RNA pathway may limit DENV replication |
|
| AAEL000028 | CLIPB34 | Immunity | Down | Serine protease involved in immune and developmental processes | Malaria parasites utilize CLIPs to sever surface proteins |
|
| AAEL014222 | Low-density lipoprotein | Cell transport | Down | Mediates receptor endocytosis | A wide variety of viruses utilize LDLs to enter host cells |
|
| AAEL008083 | 40S ribosomal protein | Cell growth and proliferation | Down | Directly involved in protein translation | Putative receptor for the entry of DENV into host cells |
|
| AAEL009888 | Bumetanide-sensitive Na-K-Cl cotransport | Transport | Down | Vital role in regulating ionic balance and cell volume |
| |
| AAEL004978 | RM62E (dead box ATP-dependent RNA helicase) | Immunity | Down | Guides the silencing of target transcripts within small RNA pathway | Small RNA pathway may limit DENV replication |
|
Table includes VectorBase gene ID, gene name, functional group, general gene function, possible association with pathogens, and associated references. ‘Up’ refers to up-regulated in the Cali-MIB strain, while ‘Down’ refers to down-regulated in the Cali-MIB strain. AMP: anti-microbial peptide; DENV: dengue virus; LDL: low-density lipoprotein; PRR: pattern recognition receptor.
Shared genes between differentially expressed genes at 24 and 48 h. GFOLD differential expression values are displayed from this study, and compared with differential expression values. GFOLD value is the normalized GFOLD log2 fold change value, the first RPKM (reads per kilobase of transcript per million mapped reads values) represents the susceptible mosquitoes, while the second RPKM corresponds to the refractory mosquitoes. Panel A is a comparison after 24 h, while panel B is after 48 h
| Vector base gene ID | GFOLD value | log2 fold change | FirstRPKM | SecondRPKM | Gene description |
| AAEL015458*** | 1.63429 | 2.09472 | 0.482571 | 4.29899 | transferrin |
| AAEL008019** | 1.15154 | 1.35835 | 8.45216 | 44.6763 | hypothetical protein |
| AAEL006911* | 1.13906 | 1.33454 | 2.89728 | 15.0603 | microtubule-associated protein |
| AAEL005091** | 0.962343 | 1.23939 | 2.49015 | 12.1359 | conserved hypothetical protein |
| AAEL005561*** | 0.92409 | 1.06373 | 4.33529 | 18.661 | plasma membrane calcium-transporting ATPase 3 (pmca3) |
| AAEL009762**** | 0.887696 | 1.40863 | 0.602798 | 3.33524 | cytochrome P450 |
| AAEL006138**^ | 0.83831 | 0.886424 | 19.4911 | 74.1502 | hypothetical protein |
| AAEL010434**^ | 0.800671 | 0.867546 | 10.7857 | 40.5015 | Vitellogenin-A1 Precursor (VG)(PVG1) |
| AAEL000940*** | 0.71424 | 0.768284 | 130.763 | 458.353 | conserved hypothetical protein |
| AAEL008413** | 0.709035 | 0.988036 | 1.21075 | 4.95468 | serine/threonine protein kinase |
| AAEL001503* | 0.659975 | 0.751801 | 8.16197 | 28.2886 | sodium/hydrogen exchanger 3 (nhe3) |
| AAEL003609** | 0.637787 | 0.917252 | 1.18354 | 4.61077 | neurobeachin |
| AAEL003733** | 0.588112 | 0.805074 | 0.806103 | 2.90214 | hypothetical protein |
| AAEL007817** | 0.571004 | 0.857399 | 0.659328 | 2.46414 | hypothetical protein |
| AAEL008234***^ | 0.565555 | 1.03674 | 0.559988 | 2.38295 | dishevelled |
| AAEL017241** | 0.540569 | 0.922035 | 1.62698 | 6.37326 | |
| AAEL006126**^ | 0.528522 | 0.597776 | 7.44993 | 23.2034 | conserved hypothetical protein |
| AAEL006563**^ | 0.49487 | 0.670025 | 7.09483 | 23.2468 | Vitellogenic carboxypeptidase Precursor (EC 3.4.16.-) |
| AAEL008216*** | 0.468322 | 0.548729 | 15.6068 | 46.9852 | aconitase |
| AAEL003331*** | 0.389598 | 1.01092 | 0.214398 | 0.901404 | hypothetical protein |
| AAEL008853*** | 0.363469 | 0.515272 | 7.3669 | 21.6768 | choline/ethanolamine kinase |
| AAEL000191*** | 0.358468 | 0.492464 | 6.24993 | 18.0997 | conserved hypothetical protein |
| AAEL006728***^ | 0.287245 | 0.577257 | 2.62092 | 8.06135 | ubiquitin-conjugating enzyme E2 c |
| AAEL013074***^ | 0.281054 | 0.373851 | 20.7738 | 55.4011 | adenylyl cyclase-associated protein |
| AAEL006785*** | 0.275308 | 0.314515 | 210.798 | 539.46 | 60S ribosomal protein L18a |
| AAEL009630** | 0.267701 | 0.519107 | 1.76691 | 5.21699 | high-affinity cgmp-specific 3,5-cyclic phosphodiesterase |
| AAEL005358**** | 0.266146 | 0.571726 | 0.924488 | 2.83316 | conserved hypothetical protein |
| AAEL000087*** | 0.230243 | 1.8899 | 0.020329 | 0.178293 | macroglobulin/complement |
| AAEL001972*** | 0.213241 | 0.571861 | 3.44608 | 10.5697 | TATA box binding protein (TBP)-associated factor, putative |
| AAEL004699*** | 0.207845 | 0.258941 | 34.393 | 84.6913 | conserved hypothetical protein |
| AAEL008329*** | 0.187807 | 0.239528 | 207.059 | 503.059 | 60S ribosomal protein L24 |
| AAEL011326***^ | 0.170562 | 0.563302 | 0.751053 | 2.29116 | conserved hypothetical protein |
| AAEL011756*** | 0.157017 | 0.213465 | 68.2496 | 162.847 | aldehyde dehydrogenase |
| AAEL013614***^ | 0.138192 | 0.220292 | 8.36298 | 20.0499 | clathrin heavy chain |
| AAEL005706*** | 0.133593 | 0.491582 | 0.733715 | 2.12793 | triacylglycerol lipase |
| AAEL013694*** | 0.112597 | 0.149466 | 277.193 | 632.684 | 40S ribosomal protein SA |
| AAEL001898*** | 0.08628 | 0.243694 | 3.39235 | 8.26768 | conserved hypothetical protein |
| AAEL006511***^ | 0.076473 | 0.117664 | 374.017 | 835.071 | ubiquitin |
| AAEL001158*** | 0.035571 | 0.379164 | 1.78576 | 4.78794 | fructose-1,6-bisphosphatase |
| AAEL001516***^ | 0.008267 | 0.172471 | 3.04556 | 7.06473 | vesicle associated protein, putative |
| AAEL011900** | 0.007043 | 0.398599 | 1.41796 | 3.85581 | N-acetyllactosaminide beta-1,3-Nacetylglucosaminyltransferase, putative |
| AAEL000026***^ | -0.02263 | -0.02764 | 0.382792 | 0.775454 | dynein light chain, putative |
| AAEL002813*** | -0.02916 | -0.15403 | 56.2173 | 103.968 | coupling factor, putative |
| AAEL013252*** | -0.08415 | -0.34997 | 2.47179 | 3.98877 | hypothetical protein |
| AAEL013407***^ | -0.08858 | -0.13579 | 64.4558 | 120.724 | catalase |
| AAEL007293***^ | -0.115 | -0.28768 | 6.79592 | 11.4547 | cAMP-dependent protein kinase catalytic subunit |
| AAEL011476***^ | -0.13368 | -0.6027 | 1.91153 | 2.58157 | conserved hypothetical protein |
| AAEL009275*** | -0.13769 | -0.29124 | 12.5854 | 21.1615 | protein phosphatase-1 |
| AAEL009658*** | -0.15448 | -0.29219 | 6.7785 | 11.3903 | alpha,alpha-trehalase |
| AAEL013979*** | -0.21581 | -0.6126 | 1.88957 | 2.5368 | conserved hypothetical protein |
| AAEL015312**** | -0.25461 | -0.38054 | 23.8955 | 37.7669 | cathepsin b |
| AAEL004181** | -0.26924 | -0.45802 | 1.12191 | 1.68004 | conserved hypothetical protein |
| AAEL002793*** | -0.32904 | -0.66303 | 1.2945 | 1.67913 | conserved hypothetical protein |
| AAEL001432*** | -0.34173 | -0.41512 | 39.1863 | 60.4723 | protein disulfide isomerase |
| AAEL012245**** | -0.44171 | -2.28002 | 0.326285 | 0.109783 | conserved hypothetical protein |
| AAEL003067**** | -0.45827 | -1.09195 | 1.07278 | 1.02269 | conserved hypothetical protein |
| AAEL002759*** | -0.46062 | -0.5438 | 17.766 | 25.0759 | tropomyosin invertebrate |
| AAEL004958**** | -0.46068 | -3.56953 | 0.110887 | 0 | conserved hypothetical protein |
| AAEL012349**** | -0.46068 | -3.56953 | 0.154968 | 0 | lipase 1 precursor |
| AAEL013566**** | -0.48876 | -1.91745 | 0.978856 | 0.494022 | C-Type lectin (CTL) - galactose binding |
| AAEL015004*** | -0.51611 | -0.79771 | 3.27493 | 3.87027 | hypothetical protein |
| AAEL004027*** | -0.59755 | -0.70559 | 26.8693 | 33.8975 | glucose dehydrogenase |
| AAEL014190**** | -0.59899 | -2.52514 | 0.189295 | 0.048122 | elongase, putative |
| AAEL009244*** | -0.61831 | -0.6692 | 195.675 | 253.206 | serine-type enodpeptidase |
| AAEL013853**** | -0.92413 | -1.80399 | 0.947571 | 0.535306 | C-Type Lectin (CTL) - galactose binding |
| AAEL013648**** | -0.93159 | -2.59552 | 0.293348 | 0.08286 | conserved hypothetical protein |
| AAEL001295**** | -1.03599 | -1.58042 | 1.66246 | 1.1286 | conserved hypothetical protein |
| AAEL002652*** | -1.14538 | -2.98457 | 0.129852 | 0.023579 | hypothetical protein |
| AAEL007942***^ | -1.25268 | -1.58534 | 7.32334 | 4.99762 | fibrinogen and fibronectin |
| AAEL017211** | -1.36322 | -1.89536 | 16.8411 | 9.17417 | cecropin anti-microbial peptide |
| AAEL001287** | -1.5998 | -3.38312 | 0.620966 | 0.084568 | conserved hypothetical protein |
| AAEL002796** | -1.78703 | -2.66264 | 0.730636 | 0.224168 | l-asparaginase i |
| AAEL008046** | -2.28638 | -2.73068 | 4.00053 | 1.22289 | rh antigen |
| AAEL003290** | -3.47153 | -6.25985 | 1.0477 | 0 | cell wall protein DAN4 precursor, putative |
| AAEL017110** | -5.13546 | -7.88489 | 7.924 | 0 | |
| AAEL009888** | -5.69755 | -7.44101 | 1.44731 | 0.008596 | bumetanide-sensitive Na-K-Cl cotransport protein, putative |
^: previously detected as differentially expressed (see below for more information), but our results show changes in the opposite direction; *: previously detected as differentially expressed in mosquitoes of the MOYO-S or MOYO-R strains infected with DENv2 Jam1409 18 h post infection; **: previously detected as differentially expressed in Chetumal (CTM) mosquito midguts 1dpi with DENv2 Jam1409 or blood; ***: previously detected as differentially expressed in mosquitoes of the MOYO-S or MOYO-D strains infected with DENv2 Jam1409 24 h post infection; ****: previously detected as differentially expressed in mosquitoes of the Rockefeller strain infected with DENv2 New Guinea C 48 h post infection.
^: previously detected as differentially expressed (see below for more information), but our results show changes in the opposite direction; ***: previously detected as differentially expressed in mosquitoes of the MOYO-S or MOYO-D strains infected with DENv2 Jam1409 48 h post infection; ****: previously detected as differentially expressed in mosquitoes of the Rockefeller strain infected with DENv2 New Guinea C 48 h post infection.